What is interesting in our study is that almost one-third of patients had negative liquid biopsy. So it’s interesting to say that we cannot say that if a patient has a negative liquid biopsy, it means that he does not have an active metastatic disease. So liquid biopsy should be interpreted with caution and these two tools should be used in a complementary way in order to determine tumor burden...
What is interesting in our study is that almost one-third of patients had negative liquid biopsy. So it’s interesting to say that we cannot say that if a patient has a negative liquid biopsy, it means that he does not have an active metastatic disease. So liquid biopsy should be interpreted with caution and these two tools should be used in a complementary way in order to determine tumor burden.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.